Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes
about
Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cellsStructure and receptor-binding properties of an airborne transmissible avian influenza A virus hemagglutinin H5 (VN1203mut)An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic levelThe antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status.Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyStructural Definition of Duck Major Histocompatibility Complex Class I Molecules That Might Explain Efficient Cytotoxic T Lymphocyte Immunity to Influenza A VirusThe cellular redox environment alters antigen presentationRevival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development.Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.Understanding the complexity and malleability of T-cell recognition.A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.Induction of multiple cytotoxic T lymphocyte responses in mice by a multiepitope DNA vaccine against dengue virus serotype 1.Building proteomic tool boxes to monitor MHC class I and class II peptides.A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes.Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02
P2860
Q27660843-81E63517-F0B5-42AE-A73C-941F2BC06598Q27678747-A037D22E-C74C-437D-8E8C-0A8EE8B4FF5FQ27684542-3A2E44E0-73F2-4EB2-8713-F9A0AB6F3A80Q30252521-98479E09-BAA6-4A6E-95D0-F622B17BAF28Q30437344-F82129A3-691D-41C8-895D-D472149E7736Q33843549-D43D69B0-C85E-410E-AF1D-4392D3C67498Q34283588-357422E0-5BC0-425A-834A-A19C32E53D72Q37844333-6045AEB7-3E9B-45E5-AE08-2541B6597C6FQ37952805-2E3DAB06-E166-41B9-8B1D-D7D1472F1FEDQ38315875-9CED6439-07F6-4CF7-A61E-ECAE2B9C9487Q38727506-FA6C492B-F013-4E2A-8F62-9976918539FCQ38899058-CDC41634-CB0A-4BF3-A3C8-6A0F5F5B4EC1Q38942473-FBF7D413-19E0-4118-BD99-80E42273F439Q39032610-468902A9-0E86-4742-8AF8-2A5BA556B3C7Q43283307-3035C7B8-F30D-4D20-9A78-332932F853CEQ57300409-B7C76090-DB99-46D5-9BC0-43274F03D440
P2860
Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@ast
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@en
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@nl
type
label
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@ast
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@en
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@nl
prefLabel
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@ast
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@en
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@nl
P2093
P2860
P50
P356
P1476
Phosphorylated self-peptides a ...... nerate tumor-specific epitopes
@en
P2093
Anne Y Zhao
Ashish K N Nair
Geordie Rudge
Hugh H Reid
Jan Petersen
Roza Nastovska
Stephanie J Wurzbacher
P2860
P304
P356
10.1073/PNAS.0812901106
P407
P577
2009-02-24T00:00:00Z